CinCor Pharma Inc.

NASDAQ: CINC · Real-Time Price · USD
29.06
0.00 (0.00%)
At close: Feb 23, 2023, 10:00 PM

CinCor Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021
Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Cash & Equivalents
292.56M 127.62M 164.6M 136.61M 141.71M
Short-Term Investments
229.94M 166.69M 149.56M n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a
Other Current Assets
6.52M 8.66M 7.49M 4.5M 5.56M
Total Current Assets
529.02M 302.98M 321.65M 141.11M 147.26M
Property-Plant & Equipment
99.72K 40.73K n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a
Total Long-Term Assets
99.72K 40.73K n/a n/a n/a
Total Assets
529.12M 303.02M 321.65M 141.11M 147.26M
Account Payables
2.59M 2.1M 4.37M 642.14K 4.01M
Deferred Revenue
n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a
Other Current Liabilities
7.59M 5.19M 1.32M 15.91M 7.54M
Total Current Liabilities
10.18M 7.28M 5.69M 16.55M 11.54M
Long-Term Debt
n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 188.27M 180.53M
Total Long-Term Liabilities
2.59M 2.1M 4.37M 188.27M 180.53M
Total Liabilities
10.18M 7.28M 5.69M 204.82M 192.07M
Total Debt
n/a n/a n/a n/a n/a
Common Stock
438.00 378.00 378.00 26.00 59.00
Retained Earnings
-136.45M -115.48M -94.4M -77.7M -48.36M
Comprehensive Income
-883.42K -711.77K -317.61K n/a n/a
Shareholders Equity
518.94M 295.73M 315.96M -63.72M -44.81M
Total Investments
229.94M 166.69M 149.56M n/a n/a